MycoMeditations has become the psilocybin retreat of choice for those who value discretion, depth, and a decade of refined therapeutic expertise.
You have probably tried the newest spa treatments, cold plunges, meditation apps, breathwork, or even given the biohacking protocols that promise more than they deliver a whirl. None of it was bad — in fact, some of it was likely genuinely pretty good.
But if you’re at a stage where you’re more interested in something that actually shifts you in a much deeper way, you’re not alone. International wellness tourists now spend 41 percent more per trip than the average traveler, according to the Global Wellness Institute — and a growing number of them are looking for experiences that go much further than recovery or relaxation.
Operating out of Jamaica since 2014, MycoMeditations is one of the longest-running psilocybin retreat centers in the world. Interest in psychedelic therapy has climbed sharply in recent years: according to a YouGov survey, one in five Americans has now tried psilocybin, and a University of Colorado study published in the Annals of Internal Medicine found that use increased across all age groups since 2019, with depression, anxiety, and chronic pain cited as the primary motivations.
MycoMeditations has been doing this work before those numbers existed. “Behind everything we do is the drive to improve and deepen the guest experience at our retreats,” Mike Ljubsa, co-owner, MycoMeditations, said over email. “Our long history has allowed us to analyze and refine every aspect of MycoMeditations over many years.”
Who goes to psilocybin retreats?
According to Ljubsa, the guests who come to MycoMeditations tend to share less in common demographically than they do in disposition. Guests typically range in age from 26 to 69 and include entrepreneurs, attorneys, doctors, military personnel, professors, psychologists, and grad students — people who have accumulated significant life experience and arrive out of genuine intention.
CEO and head facilitator Justin Townsend has been direct about what they’re signing up for: “We’re aiming to establish a gold standard for this type of experience,” he told Robb Report. “This isn’t a religious or spiritual retreat with a shaman, part of a medical study, or a recreational week for drug users.”
What happens once that group assembles is something guests consistently describe as unexpected. The professional identity people carry in — the titles, the credentials, the carefully maintained sense of who they are outside of this context — tends to fall away in the immersive environment MycoMeditations has constructed over years of refinement.
“Each retreat is different, with unique personalities and life experiences,” Ljubsa says. “Yet, everyone shares a desire to do serious personal work, and they step into this immersive healing environment together. The experience is designed to create bonds among the guests, which becomes an enormous part of the transformation in people.”
The clinical research supporting these outcomes has grown considerably more robust in recent years. A systematic review published in the journal Frontiers in Psychiatry found that psilocybin-assisted therapy produced substantial antidepressant effects lasting at least 12 months after treatment, with meaningful reductions in depressive symptoms observed after just two sessions in patients with treatment-resistant depression.
A separate meta-analysis published in PMC reviewed eight clinical trials involving 524 adult patients and found large effect sizes in favor of psilocybin, with benefits increasing at higher doses. The New England Journal of Medicine has published research showing similarly promising results for depression, anxiety, and addiction. MycoMeditations built its methodology around these kinds of outcomes before the research made headlines.
Why guests keep coming back to MycoMeditations
Roughly 25 percent of MycoMeditations guests come back for additional retreats. These are people who have come to regard this work as ongoing rather than finished, and who schedule a return the way they might schedule time for an annual reset and to progress to the next phase of their development.
“Once people experience psychedelic healing done in the way we do it, it becomes clear that psychedelics are a resource to prioritize in their lives,” Ljubsa says. “Most people just haven’t experienced what psychedelics can truly do therapeutically, which is part of what differentiates us from other retreats.”
New guests almost always arrive the same way: through someone they know: A family member who came back changed in ways that were hard to articulate but impossible to miss, a close friend who doesn’t recommend things lightly, or a colleague who shared it in confidence and with intention.
MycoMeditations doesn’t rely on advertising because the referral network it has cultivated over more than a decade is composed of people who feel confident enough in their own experience to pass it along selectively, to the right person, at the right time.
The psychedelic therapy market is projected to reach $10.75 billion by 2027, and the space will only grow louder as operators continue to enter it. What a decade of careful, iterative work produces — a defined methodology, a community of returning guests, a reputation passed hand to hand through trusted circles — is not something that can be accelerated or replicated quickly. For the people who eventually find their way to MycoMeditations, that foundation tends to be exactly what they were looking for.
Related on Ethos:
